Heska Corp. (NASDAQ:HSKA) shares reached a new 52-week high on Monday . The stock traded as high as $44.99 and last traded at $43.40, with a volume of 65,124 shares trading hands. The stock had previously closed at $43.34.

HSKA has been the topic of several research reports. CL King initiated coverage on shares of Heska Corp. in a research note on Friday, April 1st. They issued a “buy” rating on the stock. B. Riley reiterated a “buy” rating and issued a $41.50 price objective on shares of Heska Corp. in a research note on Thursday, April 28th. Zacks Investment Research upgraded shares of Heska Corp. from a “hold” rating to a “strong-buy” rating and set a $41.00 price objective on the stock in a research note on Thursday, May 5th. TheStreet upgraded shares of Heska Corp. from a “hold” rating to a “buy” rating in a research note on Wednesday, May 25th. Finally, Sidoti initiated coverage on shares of Heska Corp. in a research note on Friday, July 1st. They issued a “buy” rating and a $49.00 price objective on the stock. Five analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and a consensus price target of $46.50.

The company has a 50-day moving average of $37.77 and a 200 day moving average of $34.18. The firm has a market cap of $286.39 million and a P/E ratio of 52.52.

Heska Corp. (NASDAQ:HSKA) last released its quarterly earnings data on Tuesday, May 3rd. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.19. The firm had revenue of $27.10 million for the quarter, compared to the consensus estimate of $23.32 million. Equities research analysts forecast that Heska Corp. will post $0.85 earnings per share for the current year.

In other Heska Corp. news, CEO Kevin S. Wilson sold 11,000 shares of Heska Corp. stock in a transaction that occurred on Monday, May 9th. The shares were sold at an average price of $35.61, for a total value of $391,710.00. Following the transaction, the chief executive officer now owns 228,718 shares of the company’s stock, valued at $8,144,647.98. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michael J. Mcginley sold 5,998 shares of Heska Corp. stock in a transaction that occurred on Tuesday, May 10th. The shares were sold at an average price of $36.50, for a total transaction of $218,927.00. Following the completion of the transaction, the insider now directly owns 30,801 shares in the company, valued at approximately $1,124,236.50. The disclosure for this sale can be found here.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.